Here's where markets stand at mid-day:
-NYSE down 13.05 (-0.17%) to 7,606.89
-DJIA down 18.13 (-0.16%) to 11,163.10
-S&P 500 down 1.84 (-0.15%) to 1,194.85
-Nasdaq down 2.40 (-0.10%) to 2,511.82
Hang Seng down 0.13%
Nikkei up 0.09%
FTSE down 0.62%
MID-DAY NYSE INDEX WATCH
NYSE Energy down 0.43% at 11,665.48
NYSE Financial down 0.51% at 4,757.34
NYSE Health Care down 0.28% at 6,378.16
NYSE Arca Tech 100 up 0.67% at 1,033.25
(+) DELL (+0.2%) gains on earnings.
(+) MELA (+97%) jumps on drug developments.
(+) CRM (+15.8%) continues evening gain after Q3 beat.
(+) LVS (+3.5%) gains as Moody's hikes credit rating.
(+) ANN (+8.4%) gains on earnings.
(-/+) F (+1.0%), GM (-0.8%) down in wake of GM IPO, mixed
(-) IRE (-5.6%) down as focus on Dublin bailout persists.
Stocks are trading in a narrow range around the even mark, as
China moves to tighten its money supply to cool the economy and
control inflation and new concerns surface over efforts to quell
the Irish debt crisis, which are off-setting supportive earnings
and M&A speculation.
China's central bank hiked the reserve requirement ratio for
banks by 50 basis points. Federal Reserve Chairman Ben Bernanke,
facing global criticism for the Fed's latest bond-buying program to
recharge U.S. growth, tossed his own criticism back at Beijing's
policy to undervalue its currency against the dollar.
Meanwhile, the dollar is moving higher against a basket of
foreign currencies. The U.S. Dollar Index (
) is up 0.28%, or $0.03, to $10.66.
In company news, Google (
) shares are off session lows but still in negative territory after
Bloomberg reported the the Internet search company agreed to
improve its handling of data to prevent a repeat of the accidental
collection of information from wireless networks by its Street View
vehicles. The agreement ends the privacy investigation in the U.K.,
that country's privacy regulator reportedly said..
Shares of Pfizer (
) and Bristol-Myers Squibb (
) are down following news the two stopped a trial of their
experimental blood thinner after incidents of increased bleeding in
patients outweighed benefits for patients who recently had a heart
attack, or bad chest pain. The drug--named apixaban--is being
tested to stop heat complications in patents with acute coronary
Allied Irish Banks (
) ADRs are trading lower after it said deposits declined 17% this
year as customers pulled money out amid the ongoing debt crisis in
that country and around Europe. Deposits at the bank--Ireland's
second largest--declined by about $17.8 billion euros since the
beginning of the year. The bank said it is increasing its reliance
on monetary authorities amid the challenging funding
Boston Scientific (BSX) shares are higher after the company's
chief executive said he hoped to convince investors that it can
increase profitability over the next two years, Reuters reported,
citing the company's first analyst meeting in four years. "Sales
can't grow much more than single digits," said CEO Ray Elliott.
"The same is not true for profitability."
Del Monte Foods (DLM) is higher on reports KKR (KKR) is
preparing an $18.50 a share offer for the company. Sources say the
firms have been talking for some time and were hoping to wrap up
the deal before Del Monte reports its quarterly earnings on Dec.
Shares of General Motors (GM), which provided lift to the market
yesterday, traded down less than $1 from its $33 IPO price
yesterday. GM advanced as much as 9.1% during its first day of
trading since filing for bankruptcy last year. The U.S. Treasury
and other GM owners sold $15.8 billion in common shares at an IPO
price of $33 each, which was the second-largest U.S. IPO on
KeyCorp (KEY) shares are down following news the bank--the
second largest in Ohio--has appointed Beth Mooney CEO. She is the
first woman to lead a Top 20 U.S. bank, reported Bloomberg. Mooney
was the vice chairman of KeyCorp and head of community banking.
ExxonMobil (XOM) put a crude oil unit at its Trecate refinery in
Italy "back in operation" after a fire more than two months ago,
Bloomberg reported. The plant is slowly resuming normal production,
repairs are completed, technical checks have been made and controls
have been put in place, the report said.
In other earnings news:
--Cost Plus (CPWM) says Q3 sales were $194.6 million, a 7.3%
increase from a year ago. Net loss was $0.38 per share, down from a
loss of $1 a year ago. Q4 sales are seen between $324 million to
$330 million. EarningsWhispers says the consensus is for $329
--Dell (DELL) is higher after the computer maker late Thursday
reported its Q3 profit more than doubled and revenue surged to
$15.4 billion from $12.9 billion.
--Foot Locker (FL) is higher fueled by Q3 net income of $52
million, or $0.33 per share, easily beating an adjusted $16-million
gain last year. The Street view was for a $0.17 per share profit,
--Salesforce.com (CRM) reported Q3 non-GAAP EPS of 32 cents a
share compared to Street estimates of 31 cents a share. The company
reported revenue of $429 million compared to Street estimates of
$410.46 million. Non-GAAP diluted EPS in Q4 is expected to be in
the range of approximately $0.27 to approximately $0.28. The Street
is at 28 cents a share.
Commodities are lower as December gold contracts are down $2, or
0.13%, to $1,351 an ounce while January crude contacts are down
0.75%, or $0.60, at $81.82 a barrel.
In energy ETFs, the United States Oil Fund (USO) is down 1.41%
to $35 and the United States Natural Gas fund (UNG) is up 1.4% to
In precious metal ETFs, the SPDR Gold Trust (GLD) is down 0.12%
to $131.93. Market Vectors Gold Miners (GDX) is up 0.42% to $59.28.
iShares Silver Trust (SLV) is down 0.11% to $26.32.
Copyright (C) 2013 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.